VIVA BIOTECH (01873) · Company profile · Eqvero

VIVA BIOTECH

01873HKEX

Unit: CNY	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	1.73 bn CNY	1.99 bn CNY	2.16 bn CNY	2.38 bn CNY	2.1 bn CNY
Cost of revenue	862.84 m CNY	1.09 bn CNY	1.21 bn CNY	1.38 bn CNY	1.3 bn CNY
Research and development expense	100.46 m CNY	87.99 m CNY	127.97 m CNY	135.84 m CNY	92.38 m CNY
Selling, general and administrative expense	363.91 m CNY	364.12 m CNY	409.66 m CNY	404.45 m CNY	320.29 m CNY
Operating profit after depreciation	193.25 m CNY	229.67 m CNY	192.68 m CNY	265.98 m CNY	236.9 m CNY
Operating profit before depreciation	404.3 m CNY	443.53 m CNY	403.9 m CNY	451.43 m CNY	390.06 m CNY
EBIT	193.25 m CNY	229.67 m CNY	192.68 m CNY	265.98 m CNY	236.9 m CNY
EBITDA	404.3 m CNY	443.53 m CNY	403.9 m CNY	451.43 m CNY	390.06 m CNY
Interest expense	38.21 m CNY	55.37 m CNY	179.96 m CNY	190.09 m CNY	185.27 m CNY
Profit before tax	318 m CNY	295.71 m CNY	-55.95 m CNY	-459.17 m CNY	347.7 m CNY
Income tax expense	48.74 m CNY	73.72 m CNY	43.84 m CNY	45.06 m CNY	47.14 m CNY
Income before extraordinary items	219.76 m CNY	167.29 m CNY	-116.11 m CNY	-528.48 m CNY	287.55 m CNY

Quotes are end-of-day data. Content is for research purposes and is not investment advice.